ModeX Therapeutics, Inc.

While undermining pandemic preparedness efforts, the Health and Human Services Department’s announcement that it would “wind down” messenger RNA vaccine projects related to influenza and COVID-19 will

While undermining pandemic preparedness efforts, the Department of Health and Human Services’ announcement that it would “wind down” messenger RNA vaccine projects related to influenza and COVID-19 wi

Biopharma Acquisitions Biopharma merger and acquisition value for the second quarter of 2022 reached $25.4bn from 36 transactions, 20 of which had disclosed values. Four M&A transactions hit or exceed

Public health and biopharma leaders at a recent summit highlighted areas that need attention to be better prepared to tackle the next pandemic and also some key lessons learned as the world struggles